155 related articles for article (PubMed ID: 38596054)
1. Molecular subtype construction and prognosis model for stomach adenocarcinoma characterized by metabolism-related genes.
Sun J; Wang Y; Zhang K; Shi S; Gao X; Jia X; Cong B; Zheng C
Heliyon; 2024 Apr; 10(7):e28413. PubMed ID: 38596054
[TBL] [Abstract][Full Text] [Related]
2. Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma.
Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H
PeerJ; 2024; 12():e16776. PubMed ID: 38274323
[TBL] [Abstract][Full Text] [Related]
3. Identification of a fatty acid metabolism-related gene signature to predict prognosis in stomach adenocarcinoma.
Liu L; Sun J; Zhong C; Zhang A; Wang G; Chen S; Zhang S; Wang M; Li L
Aging (Albany NY); 2024 May; 16(10):8552-8571. PubMed ID: 38742949
[TBL] [Abstract][Full Text] [Related]
4. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes.
Li X; Lei Y
Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598
[TBL] [Abstract][Full Text] [Related]
5. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
6. Applying machine learning algorithms to develop a survival prediction model for lung adenocarcinoma based on genes related to fatty acid metabolism.
Cong D; Zhao Y; Zhang W; Li J; Bai Y
Front Pharmacol; 2023; 14():1260742. PubMed ID: 37920207
[No Abstract] [Full Text] [Related]
7. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X
Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388
[TBL] [Abstract][Full Text] [Related]
8. Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy.
Cui Z; Liu C; Li H; Wang J; Li G
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38415454
[TBL] [Abstract][Full Text] [Related]
9. Establishment of the molecular subtypes and a risk model for stomach adenocarcinoma based on genes related to reactive oxygen species.
Li G; Ping M; Zhang W; Wang Y; Zhang Z; Su Z
Heliyon; 2024 Mar; 10(5):e27079. PubMed ID: 38463816
[TBL] [Abstract][Full Text] [Related]
10. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
[No Abstract] [Full Text] [Related]
11. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
12. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
Front Oncol; 2021; 11():612952. PubMed ID: 34235071
[TBL] [Abstract][Full Text] [Related]
13. A prognostic model established using bile acid genes to predict the immunity and survival of patients with gastrointestinal cancer.
Wu X; Liu P; Wang Q; Sun L; Wang Y
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38606991
[TBL] [Abstract][Full Text] [Related]
14. Prognostic prediction using a gene signature developed based on exhausted T cells for liver cancer patients.
Zhou Y; Wu W; Cai W; Zhang D; Zhang W; Luo Y; Cai F; Shi Z
Heliyon; 2024 Mar; 10(6):e28156. PubMed ID: 38533068
[TBL] [Abstract][Full Text] [Related]
15. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a novel molecular classification incorporating oxidative stress and metabolism-related genes for stomach adenocarcinoma in the framework of predictive, preventive, and personalized medicine.
Dong Y; Yuan Q; Ren J; Li H; Guo H; Guan H; Jiang X; Qi B; Li R
Front Endocrinol (Lausanne); 2023; 14():1090906. PubMed ID: 36860371
[TBL] [Abstract][Full Text] [Related]
17. Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer.
Chen X; Zhang Z; Liao W; Zhao Y
Heliyon; 2023 Dec; 9(12):e22768. PubMed ID: 38076064
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-related molecular subtypes in lung adenocarcinoma identify novel tumor microenvironment with prognostic and therapeutic implications.
Wen H; Chen H; Xie L; Li Z; Zhang Q; Tian Q
Front Genet; 2022; 13():1012164. PubMed ID: 36263430
[No Abstract] [Full Text] [Related]
19. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
Zhou R; Peng N; Li W
Front Immunol; 2022; 13():964919. PubMed ID: 36059494
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma.
Sun D; Zhang H; Zhang C
Front Pharmacol; 2023; 14():1185418. PubMed ID: 37284310
[No Abstract] [Full Text] [Related]
[Next] [New Search]